Gastric cancer phenotype

Related entities (1)

Mentioned in (33)

Papers in which this entity is mentioned.

• Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• Deterministic evolution and stringent selection during preneoplasia. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer. (2022)
• Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA. (2022)
• Application of third-generation sequencing in cancer research. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
• Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. (2019)
• The mutational footprints of cancer therapies. (2019)
• VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
• Quantification of subclonal selection in cancer from bulk sequencing data. (2018)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Substantial contribution of extrinsic risk factors to cancer development. (2016)
• Prognostic value of inflammation-based scores in patients with osteosarcoma. (2016)
• CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma. (2015)
• Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (2015)
• Condensins are Required for Maintenance of Nuclear Architecture. (2014)
• PyClone: statistical inference of clonal population structure in cancer. (2014)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
• Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. (2012)
• Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. (2011)
• Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. (2005)

Merged raw entities (1)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.